key: cord-0804605-tcfp80ti
authors: Berrajaa, Sara; Berrichi, Samia; Bouayed, Zakaria; Mezzeoui, Sanae El; Aftiss, Fatima Zahra; Bkiyar, Houssam; Abda, Naima; Housni, Brahim
title: Diabetes as a predictive factor for severe form and high mortality risk of COVID-19: Retrospective cohort study of 188 cases
date: 2021-11-23
journal: Ann Med Surg (Lond)
DOI: 10.1016/j.amsu.2021.103095
sha: 3bacc59fe16561854fd29ccda26553d61631b0eb
doc_id: 804605
cord_uid: tcfp80ti

INTRODUCTION: Since the appearance of the first case SARS CoV 2 infection, several studies have been conducted to identify the predictive factors of mortality in patients with COVID-19. According to previous reports, diabetes seems to be associated with severe clinical forms of the new coronavirus (SARS CoV 2). Our study aimed to identify the epidemiological, clinical, radiological and prognostic profile of diabetic patients with COVID-19. METHODS: This retrospective study included diabetic patients diagnosed with COVID-19 and admitted to the Resuscitation Department of our university hospital center From Mars 1st 2020, to December 31st, 2020. RESULTS AND DISCUSSION: In this study, we collected the data of 600 patients admitted to the Anesthesia and Resuscitation Department of the Mohammed VI University Hospital of Oujda, a group of 188 (31.3%) had diabetes. The median age of our patients was 67 [25–75]. Were noted in the majority, of patients 69.6% with diabetes have developed a severe or critical injuries in the Chest CT Scan. Furthermore, we found that the mortality rate in this category of patients was higher 65/188 (34.60%) compared to non-diabetic patients, 130/412 (31.60%) (34.60%vs 31.60%; p: 0.464). CONCLUSION: Based on the results of this retrospective study, we concluded that diabetes is predictive factor for the need of an intensive care as well as a high risk of mortality related to COVID-19. Practically speaking, diabetic patients should be monitored more closely and need an aggressive preventive management protocols in order to prevent severe forms of the disease and a drastic evolution. More research is direly needed to identify patients of a higher risk of developing severe forms of COVID-19.

As of December 2019, the COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was initially identified in Wuhan, China and has rapidly become a global pandemic 1, 2 Several studies have shown that diabetes is associated with severe forms and complications of COVID-19: such as acute respiratory distress syndrome (ARDS), admission to the intensive care units (ICUs), use of mechanical ventilation, as well as a high mortality rate This chronic condition increases the risk of disabling and life-threatening complications from micro-and macro-vascular diseases 3 . Which is important to understand the special aspects of COVID-19 infection in people with this underlying comorbidity 4 .

This study was conducted for the purpose of identifying the epidemiological, clinical, radiological and prognostic profile of diabetic patients with COVID-19 managed at the Anesthesia and Resuscitation Department of Mohammed VI University Hospital of Oujda -Morocco

The objective of this 10-months long retrospective study was to determine whether diabetes is a predictive factor for the occurrence of severe forms and high rate mortality related to COVID-19 in our department.

We conducted a retrospective cohort study, mono-centric, of diabetic patients with SARS CoV 2 pneumonia hospitalized in the Anesthesia and Resuscitation Department of the Mohammed VI University Hospital of Oujda during a ten months period, from March the 1 st to December the 31 th , 2020.

Among the 600 patients gathered, a 188 had diabetes in this study were hospitalized, and diagnosed according to the World Health Organization (WHO) provisional guidelines.

Cases infected with SARS-CoV-2 were confirmed by reverse transcription-polymerase chain reaction (RT-PCR) testing of throat and nose samples or Chest CT Scan typically for Covid 19 during the study period spread over 10 months, between March 2020 and December 2020 were included in the study..

Patient's baseline characteristics were noted in the time of admission (day zero) such as medical history, Degree of pulmonary involvement, type of oxygen supplementation as well as the outcome.

The term "death due to COVID-19" according to WHO: "is a death resulting from a clinically compatible disease, in a probable or confirmed case of COVID-19, in the absence of any other obvious cause of death unrelated to the coronavirus disease" this definition was used in this work

Statistical analysis was conducted using the SPSS version 25.0. to determine the most powerful factors, such as demographic data, including age and gender, and underlying diseases affecting the mortality outcome among COVID-19 patients with diabetes, and with other comorbidities 5 .

This study does not require a formal ethical committee approval. Access to the data was authorized and approved by the head of Department.

COVID-19 is a global health crisis, challenging the preparedness of health systems' all over the world as well as the ability to cope with and sustain a pandemic response 3 . It has been clinically observed that diabetes was associated with an increased risk of developing severe forms of COVID-19 such as ARDS (acute respiratory distress syndrome) and increased mortality risk.

Many studies conducted during the recent crisis, reported that diabetes plays a critical role in the outcome of SARS-CoV-2 pneumonia. According to a Chinese data on more than 70,000 cases, the overall mortality linked to COVID-19 was 2.3% versus 7.3% in diabetic patients 6 . In the study of Guo et al. 7 , diabetic patients died much more often than non-diabetic patients (10.8% versus 3.6%).

In some other studies, it has been pointed that the COVID-19 mortality risk in pre-existing diabetes is 5-fold higher compared to individuals with normal glucose levels, while this is 10-fold higher in newly diagnosed patients 8 .

In Italy, 35% of the deceased patients were diabetic, compared to 20% of the general population in this age group: therefore; diabetics are overrepresented among the deceased patients; 70% are men with average age of 80 years old 9 .

According to our study, among the 600 cases admitted to our department, a 188 (31.3%) patients were diabetics with a higher mortality rate of 65/188 (34.60%), compared to non-diabetic patients with 130/412 deaths (31.60%).

(34.60%vs 31.60%; p: 0.464).

In our group, 67 (35.6%) diabetic patients had critical injuries between 75-100% in the Chest CT, performed during their hospitalization.

We found that diabetes was often associated with other comorbidities, such as hypertension, 101 (53.7%), cardio vascular diseases 44 (23.4%), obesity 40 (21.3%), renal failure 19 (10.1%).

In addition, in this series of cases, we concluded that diabetic patients developed several complications characterized mainly by the occurrence of acute renal failure with a percentage of 45.2%, Ischemic accidents with a rate of 22.9%, septic shock found in 20.7% of our patients, and Thrombocytopenia in 17% of cases. These results are similar to those of our study, All our patients required oxygen supplementation where 49 (26.1%) benefited from oxygenation by non-invasive ventilation (NIV) and 59 (31.4%) of diabetes patients were intubated.

While diabetes does not appear to increase the incidence of COVID-19 infection, once infected, diabetic patients have an increased risk of developing severe forms of the disease thus requiring special attention.

From our study, we can conclude that diabetic patients developed more severe pulmonary lesions, requiring the use of non-invasive ventilation or intubation with a higher mortality rate than non-diabetic patients Practically speaking, diabetic patients should be monitored more closely and need an aggressive preventive management protocols in order to prevent severe forms of the disease and a drastic evolution.

Provenance and peer review Not commissioned, externally peer-reviewed 

Tables: Table 1 : basic characteristics 

A novel coronavirus outbreak of global health concern

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Challenges of routine diabetes care during COVID-19 era: A systematic search and narrative review. Prim Care Diabetes

Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations

Clinical characteristics and outcome of hospitalized COVID-19 patients with diabetes: A single-center, retrospective study in Iran

The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China

Diabetes is a risk factor for the progression and prognosis of COVID-19

Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?

COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course

Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19

1. Name of the registry: 2. Unique Identifying number or registration ID: 3. Hyperlink to your specific registration

The following information is required for submission. Please note that failure to respond to these questions/statements will mean your submission will be returned. If you have nothing to declare in any of these categories then this should be stated.

All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.

Please state any sources of funding for your research All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state.This research did not receive any form of funding

Research studies involving patients require ethical approval. Please state whether approval has been given, name the relevant ethics committee and the state the reference number for their judgement.This study does not require a formal ethical committee approval. Access to the data was authorized and approved by the head of the department. Authors must obtain written and signed consent to publish a case report from the patient (or, where applicable, the patient's guardian or next of kin) prior to submission. We ask Authors to confirm as part of the submission process that such consent has been obtained, and the manuscript must include a statement to this effect in a consent section at the end of the manuscript, as follows: "Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request".Patients have a right to privacy. Patients' and volunteers' names, initials, or hospital numbers should not be used. Images of patients or volunteers should not be used unless the information is essential for scientific purposes and explicit permission has been given as part of the consent. If such consent is made subject to any conditions, the Editor in Chief must be made aware of all such conditions.Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.Given the retrospective design of this study, the requirement of patient consent is lifted. Data anonymity was respected in accordance with national and international guidelines

Please specify the contribution of each author to the paper, e.g. study concept or design, data collection, data analysis or interpretation, writing the paper, others, who have contributed in other ways should be listed as contributors. J o u r n a l P r e -p r o o f

In accordance with the Declaration of Helsinki 2013, all research involving human participants has to be registered in a publicly accessible database. Please enter the name of the registry and the unique identifying number (UIN) of your study.